Overcoming Barriers to HIV/AIDS Care and ART Initiation (LINC)

The study will evaluate interventions to improve engagement in HIV care following HIV diagnosis through a voluntary counseling and testing program. The specific aims are to (1) determine if a VCT-based intervention of CD4 count testing, alone or in combination with peer counseling, improves linkage to HIV/AIDS care; (2) assess the impact of the intervention on ART initiation. The study will recruit 450 HIV-positive individuals from VCTs and randomize a third to standard counseling and referral, a third to receive CD4 testing at the VCT with results return by phone after 1 weeks, and a third to receive the same CD4 testing combined with peer counseling. These combined investigations will create a comprehensive understanding of obstacles to appropriate HIV/AIDS care and result in new interventions to achieve measurable outcomes in applied settings.

Study Overview

• Status: Completed
• Conditions: Engagement in HIV Care
• Intervention / Treatment: Behavioral: Expedited CD4 testing; Behavioral: Supplemental peer counseling

• Study Type: Interventional
• Enrollment (Actual): 315
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Kenya
  • Nairobi, Kenya
    • Karen Health Center

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• At least 18 years or older and
• Testing HIV-positive for the first time at a voluntary counseling and testing (VCT) center.
• Willing to receive counseling to encourage linkage to care at a comprehensive care center (CCC).
• Willing to have a CD4 count test conducted at the enrollment visit.
• Willing to have a telephone follow-up where they may receive additional counseling and/or have their CD4 count results returned to them.
• Willing to be contacted over 1 year to determine if they linked to care.

Exclusion Criteria:

• Previous positive HIV test.
• Currently taking antiretroviral medications.
• Currently pregnant (females only).
• Currently participating in another research study or trial.
• Not planning to remain in Nairobi for the next 12 months (not including short trips out of Nairobi).

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Health Services Research
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: None (Open Label)

Number of Arms

3

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
No Intervention: Standard of care; Standard HIV counseling and referral to care
Experimental: CD4 testing; Standard HIV counseling and testing plus blood drawn for CD4 testing at time of HIV diagnosis. CD4 results are reported to participants via telephone within 1 week.	Behavioral: Expedited CD4 testing
Experimental: CD4 testing plus peer counseling; Standard HIV counseling and testing plus blood drawn for CD4 testing at time of HIV diagnosis. CD4 results are reported to participants via telephone within 1 week. Additionally, a trained peer counselor provides supplemental counseling at the time of diagnosis and at the 1 week telephone follow-up.	Behavioral: Expedited CD4 testing; Behavioral: Supplemental peer counseling

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Number of days from study enrollment until first visit to a comprehensive care center for HIV care.	An interviewer administered questionnaire will be used to determine if each participant visited a comprehensive care center. Is so, the date of the first visit will be recorded. From this, the time from enrollment until first visit to a comprehensive care center will be calculated.	1 year
Number of days from study enrollment until initiation of antiretroviral therapy.	An interviewer administered questionnaire will be used to determine if each participant started antiretroviral therapy. Is so, the date of treatment initiation will be recorded. From this, the time from enrollment until treatment initiation will be calculated.	1 year

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Interviewer-administered questionnaire to determine the number of visits made to a comprehensive care center for HIV care.	Measurement of the number of visits to a comprehensive care center will be made questionnaire administered in an in-person interview at 12 months after enrollment. The total number of visits will be recorded.	1 year
Measurement of CD4+ T-cell count.	Each participant's CD4 count will be measure at 1 year after enrollment.	1 year

Collaborators and Investigators

• Sponsor: University of Washington
• Investigators: Principal Investigator: Brandon L Guthrie, PhD, University of Washington

Study record dates

Study Major Dates

• Study Start: August 1, 2013
• Primary Completion (Actual): December 22, 2017
• Study Completion (Actual): December 22, 2017

Study Registration Dates

• First Submitted: March 11, 2016
• First Submitted That Met QC Criteria: March 23, 2016
• First Posted (Estimate): March 24, 2016

Study Record Updates

• Last Update Posted (Actual): March 13, 2019
• Last Update Submitted That Met QC Criteria: March 12, 2019
• Last Verified: March 1, 2019

More Information

Terms related to this study

• Additional Relevant MeSH Terms: RNA Virus Infections; Virus Diseases; Infections; Blood-Borne Infections; Communicable Diseases; Sexually Transmitted Diseases, Viral; Sexually Transmitted Diseases; Lentivirus Infections; Retroviridae Infections; Immunologic Deficiency Syndromes; Immune System Diseases; Slow Virus Diseases; HIV Infections; Acquired Immunodeficiency Syndrome
• Other Study ID Numbers: STUDY00000059